We showed that TACC3 harbors oncogenic properties, through stabilizing cell surface EGFR levels, and further showed that TACC3 can partially restore TKI sensitivity in NSCLC cells that are TKI resistant. The gene discussed is TACC3; the disease is non-small cell lung carcinoma.